FuxingHospital,Captital Medical University
Beijing, Beijing Municipality, 100038, China
Location status: Recruiting
Location contact
Rong L Huo, Doctor
CONTACT
Xue Yang, Master
CONTACT
Xue Yang, Master
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05085067
Retained product of conception (RPOC) is defined by abnormal trophoblastic persistence or retained placenta inside the uterus cavity after a pregnancy independently of the outcome. Untreated RPOC can compromise future fertility. RPOC are generally treated surgically, either by repeated evacuation or by hysteroscopy, which exposes the uterus to additional potential trauma.The combination of trauma to the gravid uterine cavity, hypoestrogenic state at the time of the operation or immediately afterward and local infection is considered to be the pathogenic mechanism of intrauterine adhesions (IUA) , manifested clinically by menstrual abnormalities, infertility and recurrent pregnancy loss.To investigate the efficacy of auto-cross linked hyaluronic acid gel in the prevention of adhesion reformation after hysteroscopic resection of retained products of conception.
After the completion of hysteroscopic resection of retained products of conception, patients will be randomized to one of the two groups by computer-generated numbers: [1] infusing auto-cross linked hyaluronic acid gel into intrauterine cavity in the experimental group; [2] no auto-cross linked hyaluronic acid gel into intrauterine cavity in the control group. Second and third look outpatient hysteroscopy will be performed 4 and 8 weeks after the initial surgery. The patients will be followed up about menstrual pattern at 3 months after the surgery.The patients will be followed up about pregancy outcome at 12 months after the surgery.
Interested in participating?
Request Info18 year–45 year
Female
Interventional
Not applicable
Beijing, Beijing Municipality, 100038, China
Location status: Recruiting
Rong L Huo, Doctor
CONTACT
Xue Yang, Master
CONTACT
Xue Yang, Master
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
infusing auto-cross linked hyaluronic acid gel into intrauterine cavity after hysteroscopic treatment because of retained products of conception
Time frame: A third-look hysteroscopy will be carried out 8 weeks after the initial operation.Findings are graded according to the American Fertility Society classification.
Time frame: A third-look hysteroscopy will be carried out 8 weeks after the initial operation.Findings are graded according to the American Fertility Society classification.
Time frame: at 3 months after the initial surgery
Time frame: at 12-month after the initial surgery
Time frame: up to 12 weeks
Contact information is provided by the study sponsor or research team.
Rong Li Huo, Doctor
CONTACT
Xue Yang, Master
CONTACT
Fu Xing Hospital, Capital Medical University
Other
The Efficacy of Auto-crosslinked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception:a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07074795
Abnormal Uterine Bleeding, Agnosia
Bnei Brak, Israel
View Trial DetailsNCT04804332
Retained Products of Conception
Ghent, Belgium
View Trial DetailsNCT07421895
RPOC, Retained Products of Conception
Changsha, Hunan, China
View Trial DetailsNCT07102615
Retained Products of Conception
Greenville, South Carolina, United States
View Trial Details